CSL Limited
CMXHF | OTC
$128.50
+$6.50 (+5.33%)
Sep 22, 2026, 10:06 AM ET · Market open
+5.33%
(1D)Rating
Updated: Sep 15, 2026Key Statistics
Market Data
Market Cap $61.54B
1D Range
128.50 128.50
52W Range
63.84 148.36
Valuation (TTM)
PE -23.06
PB 3.95
EV/EBITDA 13.38
Valuation (NTM)
Forward PE 19.70
Forward PEG -2.95
Price Target $213
Cash Flow
FCF Yield 4.8%
SBC Adj. FCF Yield 4.8%
SBC Impact N/A
Margins
Gross Margin 47.8%
Operating Margin 25.6%
FCF Margin 17.7%
Growth (CAGR)
Revenue 3Y | 5Y 30.5% |
13.6%
Dil EPS 3Y | 5Y -297.0% |
-68.0%
FCF 3Y | 5Y 29.5% |
24.5%
Returns
ROA -7.5%
ROE -15.1%
ROIC 10.0%
Financial Health
Net Debt
$8B
Current Ratio 2.21
Interest Coverage 9.34
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
22 days ago · cnbc.com
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakersNearly a dozen drugmakers are reportedly slated to voluntarily sell their medications at lower prices under deals expected to be announced by President Donald Trump on Monday. The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
Add to Watchlist
Select watchlists to add or remove CMXHF